Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/10261/2972
Full metadata record
DC FieldValueLanguage
dc.creatorSolà, Anna M.-
dc.creatorRoselló-Catafau, Joan-
dc.creatorGelpí, Emili-
dc.creatorHotter, Georgina-
dc.date2008-02-18T18:19:44Z-
dc.date2008-02-18T18:19:44Z-
dc.date2001-02-
dc.date.accessioned2017-01-31T01:00:11Z-
dc.date.available2017-01-31T01:00:11Z-
dc.identifierGut. 2001 February; 48(2): 168–175.-
dc.identifierhttp://dx.doi.org/10.1136/gut.48.2.168-
dc.identifier0017-5749-
dc.identifierhttp://hdl.handle.net/10261/2972-
dc.identifier10.1136/gut.48.2.168-
dc.identifier.urihttp://dspace.mediu.edu.my:8181/xmlui/handle/10261/2972-
dc.description[BACKGROUND AND AIMS] Inhibition of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by nitric oxide (NO) in intestinal preconditioning could modify the rate of formation of glycolytic intermediates. Fructose-1,6-biphosphate (F16BP) is a glycolytic intermediate that protects tissue from ischaemia/reperfusion injury. We evaluated if F16BP may be endogenously accumulated as a consequence of GAPDH inhibition by NO during intestinal preconditioning in rats.-
dc.description[METHODS] We assessed: (1) effect of preconditioning on F16BP content; (2) effect of NO on GAPDH activity before and during sustained ischaemia; and (3) protective effect of F16BP in control, ischaemic, and preconditioned animals with or without administration of N-nitro-L-arginine methyl ester (L-NAME), NO donor, or F16BP.-
dc.description[RESULTS] Preconditioned rats showed a significant transient decrease in GAPDH activity and also maintained basal F16BP levels longer than ischaemic rats. L-NAME administration to preconditioned rats reversed these effects. F16BP administration to ischaemic rats decreased protein release in the perfusate. Administration of F16BP to L-NAME treated rats attenuated the harmful effect of L-NAME.-
dc.description[CONCLUSIONS] Our study indicates that F16BP may be endogenously accumulated in preconditioned rats as a consequence of inhibition of GAPDH by NO, and this may contribute to the protection observed in intestinal preconditioning.-
dc.descriptionThis work was supported by grant FIS 98/002901. A Sola was supported by a grant from Institut d’Investigacions Biomèdiques August Pi I Sunyer.-
dc.descriptionPeer reviewed-
dc.format75510 bytes-
dc.format74796 bytes-
dc.format48177 bytes-
dc.format46852 bytes-
dc.format20011 bytes-
dc.format154667 bytes-
dc.format55006 bytes-
dc.formatimage/jpeg-
dc.formatimage/jpeg-
dc.formatimage/jpeg-
dc.formatimage/jpeg-
dc.formatimage/jpeg-
dc.formatapplication/pdf-
dc.formatimage/jpeg-
dc.languageeng-
dc.publisherBMJ Publishing Group-
dc.relationhttp://dx.doi.org/10.1136/gut.48.2.168-
dc.rightsopenAccess-
dc.subjectFructose-1,6-biphosphate-
dc.subjectGlyceraldehyde- 3-phosphate dehydrogenase-
dc.subjectIntestinal preconditioning-
dc.subjectIschaemia/reperfusion injury-
dc.subjectNitric Oxide-
dc.titleFructose-1,6-biphosphate in rat intestinal preconditioning: involvement of nitric oxide-
dc.typeArtículo-
Appears in Collections:Digital Csic

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.